CDKN2A as transcriptomic marker for muscle-invasive bladder cancer risk stratification and therapy decision-making. - Worst, Thomas S.; Weis, Cleo-Aron; Stöhr, Robert; Bertz, Simone; Eckstein, Markus; Otto, Wolfgang; Breyer, Johannes; Hartmann, Arndt; Bolenz, Christian; Wirtz, Ralph M.; Erben, Philipp (Scientific Reports, 2018)